DOCSLIB.ORG

The Treatment-Resistant Catatonia Patient Ahmed Aboraya, MD, Drph, Paramjit Chumber, MD, and Bahar Altaha, MD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Treatment-Resistant Catatonia Patient Ahmed Aboraya, MD, Drph, Paramjit Chumber, MD, and Bahar Altaha, MD Cases That Test Your Skills The treatment-resistant catatonia patient Ahmed Aboraya, MD, DrPH, Paramjit Chumber, MD, and Bahar Altaha, MD How would you Ms. R develops severe catatonia after being hospitalized handle this case? with agitation, delusions, and hallucinations. A Visit CurrentPsychiatry.com to input your answers benzodiazepine does not help. How would you treat her? and see how your colleagues responded CASE Worsening psychosis tor Ms. R and administer haloperidol as needed, Ms. R, age 21, is admitted to our psychiatric 10 mg total. Eight days after admission, she de- facility while experiencing paranoid delusions velops severe catatonia. On the catatonia scale ® and auditory hallucinations.Dowden Upon admission, Health of the MediaSCIP, Ms. R scores the maximum on mea- she is agitated and her mood is labile. sures of immobility, catalepsy/waxy fl exibility, CopyrightMs. R has 4 previousFor briefpersonal psychiatric admis- use andonly mutism (Table). sions and was diagnosed with schizoaff ective disorder, bipolar type and moderate mental How would you treat Ms. R’s catatonia? retardation. Her family history is positive for a) restart ziprasidone and lithium psychiatric illness, as her mother was diag- b) refer her for medical evaluation to rule nosed with schizophrenia. Prior to admission, out organic causes of catatonia Ms. R was taking ziprasidone, 160 mg/d, and c) prescribe a benzodiazepine d) try a diff erent antipsychotic lithium, 450 mg/d, for 11 months. Both were discontinued during the fi rst week of admis- sion because Ms. R was not responding. The authors’ observations During this admission, the treating psy- DSM-IV-TR recognizes catatonia as a schizo- chiatrist assesses Ms. R using the Schedules phrenia subtype, as a descriptor for mania for Clinicians’ Interview in Psychiatry (SCIP), an and major depression, and as being caused instrument developed by the lead author (AA) by various medical conditions, such as for psychiatrists to use in conjunction with their neuroleptic malignant syndrome, encepha- routine clinical interviews in inpatient and out- lopathy, or renal failure.2 Kahlbaum initially patient settings (see Related Resources, page described catatonia in 1873 as a brain dis- 68). The SCIP includes a 25-question screening ease characterized by motor abnormalities section and a diagnostic section that consists such as akinesia, rigidity, negativism, mut- of 7 modules that represent major psychiatric ism, grimacing, posturing, catalepsy, waxy diagnoses defi ned by DSM and International fl exibility, and verbigerations.3 Catatonia Classifi cation of Diseases criteria.1 is characterized by hypo- and hyperkinetic During the fi rst week of admission, we moni- features. Catalepsy, stupor, rigidity, and cata- tonic posturing with waxy fl exibility might Dr. Aboraya is chief of psychiatry, William R. Sharpe, alternate with violent catatonic excitement.4 Jr. Hospital, Weston, WV. Drs. Chumber and Altaha are Catatonia can be life-threatening; patients Current Psychiatry assistant professors of psychiatry, West Virginia University, 66 March 2009 Morgantown. might not be able to eat or chew food, which For mass reproduction, content licensing and permissions contact Dowden Health Media. 66_CPSY0309 66 2/13/09 10:52:57 AM Cases That Test Your Skills Table Patient’s catatonia symptoms: Response to pharmacotherapy Risperidone Lorazepam + Risperidone long-acting Lorazepam only risperidone oral only injection only Dosage(s) 7 mg total over Lorazepam: 4 mg/d 8 mg/d 37.5 mg every 7 days Risperidone: 4 mg/d 2 weeks Scores on SCIP catatonia scale:* Immobility 2 1 0 0 Catalepsy/ waxy fl exibility† 2 1 0 0 Mutism 2 0 0 0 Clinical Point Total score 6 2 0 0 Atypical *Scale of 0 to 2, with 0=none, 1=less than half the time, and 2=more than half the time. Symptoms are evaluated over a 1-day period †For this category, 0=none, 1=brief (usually <1 minute) episodes of ‘freezing’ in a position, and 2=episodes of ‘freezing’ in a position antipsychotics may for >1 minute SCIP: Schedules for Clinicians’ Interview in Psychiatry alleviate catatonia motor symptoms by virtue of their c) add a diff erent antipsychotic to lorazepam puts them at risk for aspiration. Those with 5-HT2A receptor immobility might not move to urinate or d) administer electroconvulsive therapy (ECT) defecate. During the fi rst half of the 20th antagonistic action century, catatonia was documented in up to 50% of patients with schizophrenia.5 The authors’ observations Since then, the incidence of catatonia has Benzodiazepines and ECT are effective decreased, possibly the result of advances treatments for catatonia.7 Benzodiazepines in psychopharmacology.6 are considered fi rst-line treatment because Two days after Ms. R develops catato- of their effi cacy and favorable side-effect nia, we transfer her to a local hospital for profi le.7 Lorazepam frequently is used to evaluation to rule out a medical cause of treat catatonia in the short term.8 Long- her catatonic symptoms. term use of benzodiazepines, however, is associated with tolerance, addiction, and rebound phenomena.8,9 EVALUATION No medical cause Patients with catatonia who do not re- At the hospital, physical examination, elec- spond to benzodiazepines may benefi t troencephalography, drug screening, and from ECT.9 ECT can cause serious side ef- liver and thyroid function tests are within fects, however, including memory impair- normal limits, eliminating an organic cause ment, confusion, delirium, and cardiac of Ms. R’s catatonia. MRI of the head shows a arrhythmias.10 3-mm mass at the base of the infundibulum, Atypical antipsychotics may alleviate which is unchanged from a prior MRI. Ms. R motor symptoms of catatonia by virtue of received 7 mg total of lorazepam over 4 days without relief of her catatonia. She is trans- ferred back to our facility. For more information, go to CurrentPsychiatry.com What step would you try next? catatonia, Carroll a) switch to a diff erent benzodiazepine Current Psychiatry Current Psychiatry b) add risperidone to lorazepam Vol. 8, No. 3 67 67_CPSY0309 67 2/17/09 11:24:55 AM Cases That Test Your Skills their 5-HT2A receptor antagonistic action.9 In 2 case reports, risperidone successfully Related Resources treated catatonia.4,11 Kopala et al11 found • Schedules for Clinicians’ Interview in Psychiatry (SCIP). Available from Ahmed Aboraya, [email protected]. risperidone, 4 mg/d, was effective in treat- • Valevski A, Loebl T, Keren T, et al. Response of catatonia ing severe, fi rst-episode catatonic schizo- to risperidone: two case reports. Clin Neuropharmacol. phrenia in a neuroleptic-naive young man. 2001;24(4):228-231. This effi cacy was sustained over a 3.5-year • Van Den Eede F, Van Hecke J, Van Dalfsen A, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur outpatient follow-up. Psychiatry. 2005;20(5-6):422-429. In another report, risperidone, 6 mg/d, Drug Brand Names effectively treated catatonia and prevented Haloperidol • Haldol Risperidone • Risperdal further episodes in a patient with schizo- Lithium • Eskalith, Lithobid Risperidone long-acting Lorazepam • Ativan injection • Risperdal Consta phrenia who developed severe catatonia af- Olanzapine • Zyprexa Ziprasidone • Geodon Clinical Point ter receiving adequate treatment for Lyme Disclosure disease with encephalitis.4 Two relapses of We recommend The authors have no fi nancial relationship with any company catatonic syndrome occurred when risperi- whose products are mentioned in this article or with manufacturers of competing products. using risperidone done was reduced to 2 mg/d, and remission to treat catatonia in occurred after risperidone was increased to psychotic patients 6 mg/d. Risperidone’s antagonistic activity days later, her catatonic symptoms decrease who do not respond of the 5-HT2/D2 receptors may be relevant substantially—she scores 2/6 on the SCIP 12 catatonia scale ( )—and she to a benzodiazepine to its anticatatonic effect. Table, page 67 Other atypical antipsychotics—zipra- starts to talk with the staff . sidone and olanzapine—also have been We continue this regimen for 30 days, then shown to be effective in treating catato- discontinue lorazepam to avoid long-term nia. Levy et al13 reported successful treat- side eff ects—such as dependence—and ti- ment of a catatonic state (with catalepsy, trate risperidone to 8 mg/d. Ms. R continues to stupor, and mutism) using intramuscular improve while taking risperidone only. Twen- ziprasidone followed by oral ziprasidone. ty-three days after stopping lorazepam, she is A data analysis by Martenyi et al14 showed free of catatonic symptoms, scoring 0/6 on the olanzapine to be effective in treating non- SCIP catatonia scale. specifi c signs and symptoms of catatonia, We discharge Ms. R on risperidone. Because as measured by the Positive and Negative she has a history of medication nonadherence, Syndrome Scale. we prescribe risperidone long-acting injection, 37.5 mg every 2 weeks, while continuing oral risperidone for 3 weeks after the fi rst injection. TREATMENT Trying risperidone She does well on this medication, experienc- Based on case reports showing risperidone’s ing no catatonic symptoms or adverse eff ects effi cacy for catatonia, we start Ms. R on risperi- over the next 15 months as measured by the done, 4 mg/d, and lorazepam, 4 mg/d. Eight SCIP assessment. Bottom Line Benzodiazepines and electroconvulsive therapy are eff ective treatments for catatonia but each carries the risk of adverse eff ects. Case reports suggest risperidone is eff ective in short- and long-term treatment of catatonia and can be Current Psychiatry 68 March 2009 added to benzodiazepines in patients with delusions or hallucinations. 68_CPSY0309 68 2/17/09 11:25:01 AM Cases That Test Your Skills IN THE UNITED STATES, THE PRESS CANNOT The authors’ observations BE CENSORED. This is the third case report in the literature to show that risperidone is effective in short- and long-term THE INTERNET treatment of catatonia.4,11 Although Ms.
Load more

Recommended publications
  • Psychosis, Catatonia and Post-Psychosis PTSD
    British Journal of Medicine & Medical Research 15(8): 1-5, 2016, Article no.BJMMR.26114 ISSN: 2231-0614, NLM ID: 101570965 SCIENCEDOMAIN international www.sciencedomain.org Psychosis, Catatonia and Post-psychosis PTSD Evita Rocha 1, Andrei Novac 2, Daniel Kirsten 1, Jiwon Shin 3, Diana Totoiu 4 and Robert G. Bota 3* 1Resident Psychiatry, UC, Irvine, USA. 2Department of Psychiatry, UC, Irvine, USA. 3UC Irvine, USA. 4Department of Psychology, Cal State Fullerton, USA. Authors’ contributions This work was carried out in collaboration between all authors. Author ER wrote the first draft of the case reports and helped with literature search and part of introduction. Author AN contributed the writing of the manuscript and formulated the theoretical frame of the psychopathology. Authors DK, JS, DT managed the literature searches, contributed to writing of the manuscript and edited the final versions. Author RGB designed the study, supervised the process and wrote parts of the manuscript. All authors read and approved the final manuscript. Article Information DOI: 10.9734/BJMMR/2016/26114 Editor(s): (1) Domenico De Berardis, Department of Mental Health, National Health Service, Psychiatric Service of Diagnosis and Treatment, “G. Mazzini” Hospital, Italy. Reviewers: (1) Sara Marelli, Vita-Salute San Raffaele University, Milan, Italy. (2) Takashi Ikeno, National Center of Neurology and Psychiatry, Japan. Complete Peer review History: http://sciencedomain.org/review-history/14521 Received 1st April 2016 nd Case Study Accepted 2 May 2016 Published 9th May 2016 ABSTRACT We are describing the case of a 27-year-old female with no previous psychiatric history who developed post-psychotic PTSD after presenting with first episode catatonia and psychosis.
    [Show full text]
  • Cannabis-Induced Catatonia: a Case Series
    Open Access Case Report DOI: 10.7759/cureus.8603 Cannabis-Induced Catatonia: A Case Series Hema Mekala 1 , Zamaar Malik 2 , Judith Lone 2 , Kaushal Shah 1 , Muhammad Ishaq 1 1. Psychiatry, Griffin Memorial Hospital, Norman, USA 2. Psychiatry, Medical University of the Americas, Camps, KNA Corresponding author: Kaushal Shah, [email protected] Abstract Catatonia is a psychomotor condition characterized by physical presentations ranging from severe immobility to excessive psychomotor agitation with an array of accompanying emotional aspects. Though initially thought to be a subform of schizophrenia, it is now recognized to be associated with many different psychiatric, neurological, and medical diagnoses. The emergence of catatonia is becoming more prevalent with its changing pattern and extensive use of recreational and illegal drugs. With the legalization of marijuana, its use is on the rise leading to several mental health conditions, including catatonia. If left untreated, catatonia has a significant morbidity and mortality rate; hence, prompt evaluation and diagnosis are critical for the prevention of adverse events. Benzodiazepines (BZDs) and electroconvulsive therapy (ECT) have been found to be most effective and remained as the preferred treatment options. In this paper, we present the case of two patients who presented with catatonia after cannabis consumption and discuss their treatment course and management. Categories: Emergency Medicine, Neurology, Psychiatry Keywords: synthetic cannabis, k2, cannabis, catatonia, addiction, thc, schizophrenia, benzodiazepine, ect, psychiatry Introduction Catatonia is a common condition observed in acutely ill patients with mental health conditions. In the United States, approximately 90,000 people tend to suffer from catatonia each year, with a prevalence ranging between 7.6% to 38% [1].
    [Show full text]
  • The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1
    The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1 Psychotic Disorders Slide 2 As with all the disorders, it is preferable to pick Archetype one “archetypal” disorder for the category of • Schizophrenia disorder, understand it well, and then know the others as they compare. For the psychotic disorders, the diagnosis we will concentrate on will be Schizophrenia. Slide 3 A good way to organize discussions of Phenomenology phenomenology is by using the same structure • The mental status exam as the mental status examination. – Appearance –Mood – Thought – Cognition – Judgment and Insight Clinical Presentation of Psychotic Disorders. Slide 4 Motor disturbances include disorders of Appearance mobility, activity and volition. Catatonic – Motor disturbances • Catatonia stupor is a state in which patients are •Stereotypy • Mannerisms immobile, mute, yet conscious. They exhibit – Behavioral problems •Hygiene waxy flexibility, or assumption of bizarre • Social functioning – “Soft signs” postures as most dramatic example. Catatonic excitement is uncontrolled and aimless motor activity. It is important to differentiate from substance-induced movement disorders, such as extrapyramidal symptoms and tardive dyskinesia. Slide 5 Disorders of behavior may involve Appearance deterioration of social functioning-- social • Behavioral Problems • Social functioning withdrawal, self neglect, neglect of • Other – Ex. Neuro soft signs environment (deterioration of housing, etc.), or socially inappropriate behaviors (talking to themselves in
    [Show full text]
  • Movement Disorders in Catatonia Subhashie Wijemanne, Joseph Jankovic
    Movement disorders J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2014-309098 on 19 November 2014. Downloaded from REVIEW Movement disorders in catatonia Subhashie Wijemanne, Joseph Jankovic ▸ Additional material, ABSTRACT between 7.6% and 38% among all psychiatric including videos, is published Catatonia is a complex neuropsychiatric syndrome patients.10 The percentage of catatonia due to a online only. To view please characterised by a broad range of motor, speech and general medical condition is reported to range visit the journal online (http:// 11 dx.doi.org/10.1136/jnnp-2014- behavioural abnormalities. ‘Waxy flexibility’, ‘posturing’ from 20% to 39%. Catatonia may be subtle and 309098). and ‘catalepsy’ are among the well-recognised motor overlooked, which may account for reports suggest- Department of Neurology, abnormalities seen in catatonia. However, there are ing a declining incidence. People with bipolar disor- Parkinson’s Disease Center and many other motor abnormalities associated with ders probably constitute the largest subgroup of Movement Disorders Clinic, catatonia. Recognition of the full spectrum of the catatonic patients.51012In a minority of cases, no Baylor College of Medicine, phenomenology is critical for an accurate diagnosis. cause is found and the current prevalence of idio- Houston, Texas, USA Although controlled trials are lacking benzodiazepines pathic catatonia is unknown. Correspondence to are considered first-line therapy and N-Methyl-D- Owing to the wide range of underlying diagnoses, Dr Joseph Jankovic, aspartate receptor antagonists also appears to be patients with catatonia may present as a medical or Department of Neurology, effective. Electroconvulsive therapy is used in those psychiatric emergency13 or develop symptoms ’ Parkinson s Disease Center and patients who are resistant to medical therapy.
    [Show full text]
  • Presence of Isolated Catatonic Signs in Chronic Psychosis
    JOURNAL OF PSYCHOPATHOLOGY Case report 2018;24:237-238 K. Navin, G. Sathyanarayanan, Presence of isolated catatonic signs B. Bharadwaj in chronic psychosis: Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education & is chronic catatonia under-recognised? Research, Puducherry, India A case series Introduction Catatonia is a complex syndrome of specific motor abnormalities associ- ated with various psychiatric disorders. Historically, more than 50 clinical signs have been described in catatonia, however, it is now confined to the 23 signs mentioned in the Bush-Francis Catatonia Rating Scale 1. In clinical practice we are apt to recognise catatonia in its stuporous form presenting in emergency with risks due to compromised food and water intake and immobility. Excited catatonia is often missed or diagnosed in hindsight when it presents with manic excitement 2. In this case series we want to highlight that the presence of a few catatonic signs may often be missed as has been pointed out earlier 3. This under-recognition may account for the discrepancy between findings in literature 4. In the Inter- national Pilot Study of Schizophrenia (IPSS) though catatonic signs were noted in 96 patients only a few among them were diagnosed as catatonic schizophrenia. Conversely, most of the 55 patients diagnosed as having catatonic schizophrenia did not have catatonic symptoms 5. In this case series, we would like to present three patients with persistent catatonic symptoms occurring during their psychotic illnesses. The cata- tonic signs were recognized on clinical evaluation. The signs specifically re- sponded to treatment with lorazepam and in two of the cases, drug default or attempts to taper the dose; led to resurgence of catatonic symptoms.
    [Show full text]
  • Catatonia: an Under-Recognised, Acutely Treatable Condition in Young People with Intellectual Disability/ASD
    Catatonia: an under-recognised, acutely treatable condition in young people with intellectual disability/ASD. Associate Professor David Dossetor The Children’s Hospital at Westmead Area Director for Mental Health Child Psychiatrist with a Special interest in Intellectual Disability A case example inaudible words in the consultation and didn’t A 15-year-old girl with Down Syndrome was referred to respond to questions. She had waxy flexibility and neurology due to a neurocognitive decline over a two- mild increased muscle tone. She drew a few small month period. She had been socially active, happy, indistinct pictures and was eventually able to write cheeky, talkative and an enthusiastic school attender. her name. She appeared to respond to unseen She had acquired basic self-care and hygiene skills, stimuli. There was no access to her internal mental and achieved primary school educational skills. At a state but she did laugh to herself regularly, out of school swimming carnival, the girl was severely context. It was not possible to assess her cognitive sunburnt. That night she became a little delirious and skills. was uncharacteristically incontinent; this incontinence persisted. The next day she was found sitting in bed The girl was diagnosed with a psychotic disorder with with arms out stiff and staring blankly. A GP review catatonic features and started on olanzapine 2.5mg revealed nothing, with a normal urine screen. Over the three times daily (tds), adding 0.5mg lorazepam tds next month she became progressively quieter until she a week later which was increased to 1mg tds two became mute. She also became apathetic and lost weeks later.
    [Show full text]
  • Neutrophil-Lymphocyte Ratio in Catatonia
    Original article Neutrophil-lymphocyte ratio in catatonia SENGUL KOCAMER SAHIN1 https://orcid.org/0000-0002-5371-3907 CELAL YAşAMALI1 https://orcid.org/0000-0002-2813-2270 MUHAMMET BERKAY ÖZYÜREK2 https://orcid.org/0000-0002-7016-1411 GÜLÇIN ELBOğA1 https://orcid.org/0000-0003-3903-1835 ABDURRAHMAN ALTINDAğ1 https://orcid.org/0000-0001-5531-4419 AHMET ZIYA şAHIN3 https://orcid.org/0000-0001-5853-8709 1 Department of Psychiatry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. 2 Department of Psychiatry, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey. 3 Department of Internal Medicine, Faculty of Medicine, Sanko University, Gaziantep, Turkey. Received: 05/18/2019 – Accepted: 01/14/2020 DOI: 10.1590/0101-60830000000232 Abstract Background: There is growing evidence of subclinical inflammation in mental disorders. Objective: The aim of this study was to investigate frequency of symptoms of catatonia and the newly diagnosed subclinical inflammatory markers which are neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR), monocyte/lymphocyte (MLR) ratios in catatonia patients due to mental disorders. Methods: Patients who were admitted to psychiatry clinic with the diagnosis of catatonia according to DSM 5 in the last two years and equal number of control group were included in this retrospective study. Univariate analysis of covariance controlled for possible confounders was used to compare NLR, PLR, MLR ratios between patients and the control group. Results: A total of 34 catatonia patients and 34 healthy controls were included in the study. Patients’ mean age was 30.88 + 13.4. NLR value was significantly higher in the patient group than control group. There was no significant difference between the patients and control group according to PLR, MLR values.Discussion: The presence of subclinical inflammation in catatonic syndrome due to mental disorders should be considered.
    [Show full text]
  • Catatonia in Depression: Prevalence, Clinical J Neurol Neurosurg Psychiatry: First Published As 10.1136/Jnnp.60.3.326 on 1 March 1996
    32632ournal ofNeurology, Neurosurgery, and Psychiatry 1996;60:326-332 Catatonia in depression: prevalence, clinical J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.3.326 on 1 March 1996. Downloaded from correlates, and validation of a scale Sergio E Starkstein, Gustavo Petracca, Alejandra Teson, Eran Chemerinski, Marcelo Merello, Ricardo Migliorelli, Ramon Leiguarda Abstract mute and immobile, with staring expression, Objectives-To examine the clinical cor- gaze fixed into space, with an apparent com- relates of catatonia in depression, to vali- plete loss of will, no reaction to sensory stim- date a scale for catatonia, and to assess uli, sometimes with the symptom of waxy the validity of the DSM-IV criteria of the flexibility completely developed, as in catatonic features specifier for mood dis- catalepsy, sometimes of a mild degree, but orders. clearly recognisable," and labelled this state Methods-A series of 79 consecutive "vesania katatonica".2 Stressing that catatonia patients with depression and 41 patients was not related to "affective" melancholy with Parkinson's disease without depres- sensu strictu, Wernicke suggested the term sion were examined using the modified "motilitatpsychose", and suggested that this Rogers scale (MRS), the unified disorder may be the result of dysfunction of a Parkinson's disease rating scale "psychomotor path", producing either akine- (UPDRS), and the structured clinical sis, parakinesis, or hyperkinesis.3 Whereas interview for DSM-III-R (SCID). Kahlbaum and Wernicke placed catatonia Results-Sixteen of the 79 depressed within the range of the affective disorders, patients (20%) had catatonia. Depressed Kraepelin4 considered catatonia as a type of patients with catatonia had significantly schizophrenia, and this disorder aroused little higher scores on the MRS than non-cata- interest until recently.
    [Show full text]
  • Catatonia Associated with Late-Life Psychosis Successfully Treated With
    Sugawara et al. Ann Gen Psychiatry (2021) 20:14 https://doi.org/10.1186/s12991-021-00336-4 Annals of General Psychiatry CASE REPORT Open Access Catatonia associated with late-life psychosis successfully treated with lithium: a case report Hiroko Sugawara1,2*, Junpei Takamatsu3, Mamoru Hashimoto2 and Manabu Ikeda2 Abstract Background: Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agita- tion, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electrocon- vulsive therapy (ECT) are safe and efective standard treatments for catatonia; however, alternative treatment strate- gies have not been established in cases where these treatments are either inefective or unavailable. Here, we report a case of catatonia associated with late-life psychosis, which was successfully treated with lithium. Case presentation: A 66-year-old single man with hearing impairment developed hallucination and delusions and presented with catatonic stupor after a fall. He initially responded to benzodiazepine therapy; however, his psychotic symptoms became clinically evident and benzodiazepine provided limited efcacy. Blonanserin was inefective, and ECT was unavailable. His catatonic and psychotic symptoms were fnally relieved by lithium monotherapy. Conclusions: Catatonic symptoms are common in patients with mood disorders, suggesting that lithium may be efective in these cases. Moreover, lithium may be efective for both catatonic and psychotic symptoms, as it nor- malizes imbalances of excitatory and inhibitory systems in the brain, which underlies major psychosis. Cumulative evidence from further cases is needed to validate our fndings. Keywords: Catatonia, Late-life psychosis, Lithium, Benzodiazepine, Psychotic symptoms Background schizophrenia (10–15%) [5]. A prospective cohort study Catatonia is a psychomotor syndrome that presents vari- has also reported the incidence of catatonia to be only ous symptoms ranging from stupor to agitation, with 7.6% in patients with schizophrenia [6].
    [Show full text]
  • The Harmony of Illusions the Harmony of Illusions
    THE HARMONY OF ILLUSIONS THE HARMONY OF ILLUSIONS I NVENTING POST-TRAUMATIC STRESS DISORDER Allan Young PRINCETON UNIVERSITY PRESS PRINCETON, NEW JERSEY Copyright 1995 by Princeton University Press Published by Princeton University Press, 41 William Street, Princeton, New Jersey 08540 In the United Kingdom: Princeton University Press, Chichester, West Sussex All Rights Reserved Library of Congress Cataloging-in-Publication Data Young, Allan, 1938– The harmony of illusions : inventing post-traumatic stress disorder / Allan Young. p. cm. Includes bibliographical references and index. ISBN 0-691-03352-8 (cloth : alk. paper) 1. Post-traumatic stress disorder—Philosophy. 2. Social epistemology. I. Title. RC552.P67Y68 1995 616.85′21—dc20 95-16254 This book has been composed in Times Roman Princeton University Press books are printed on acid-free paper and meet the guidelines for permanence and durability of the Committee on Production Guidelines for Book Longevity of the Council on Library Resources Printed in the United States of America by Princeton Academic Press 10987654321 For Roberta Contents Acknowledgments ix Introduction 3 PART I: THE ORIGINS OF TRAUMATIC MEMORY One Making Traumatic Memory 13 Two World War I 43 PART II: THE TRANSFORMATION OF TRAUMATIC MEMORY Three The DSM-III Revolution 89 Four The Architecture of Traumatic Time 118 PART III: POST-TRAUMATIC STRESS DISORDER IN PRACTICE Five The Technology of Diagnosis 145 Six Everyday Life in a Psychiatric Unit 176 Seven Talking about PTSD 224 Eight The Biology of Traumatic Memory 264 Conclusion 287 Notes 291 Works Cited 299 Index 321 Acknowledgments I OWE a debt to colleagues and friends in the Department of Social Studies of Medicine and the Department of Psychiatry at McGill University: I thank Don Bates, Alberto Cambrosio, Margaret Lock, Faith Wallis, George Weisz, and Laurence Kirmayer for their invaluable advice.
    [Show full text]
  • Catatonia and Psychosis Related to Epilepsy: a Case Report Laiana Quagliato 1, Roberto Piedade 1, Cristina Santana 2, Elie Cheniaux 1
    Case Reports Catatonia and Psychosis Related to Epilepsy: A Case Report Laiana Quagliato 1, Roberto Piedade 1, Cristina Santana 2, Elie Cheniaux 1 Abstract Although a variety of metabolic, toxic, psychiatric, and neurologic conditions can produce catatonic syndromes, it is less widely recognized that this state may be caused by epilepsy. We present the case of a woman with catatonic behavior, which she could not recall. She also exhibited olfactory, auditory and visual hallucinations. An EEG demonstrated dif- fuse abnormal electrical activity, mainly on left temporal and frontal areas. Treatment with anticonvulsant drugs yielded excellent response. Key Words: Temporal Lobe Epilepsy, Catatonic Syndrome, Epileptic Psychosis Introduction To illustrate the importance of diagnosing catatonic syn- Catatonia is a syndrome characterized by motor dysreg- dromes properly, we report the case of a patient with cata- ulation and speech disorders (1). A variety of conditions can tonic behavior, auditory, visual and olfactory hallucinations produce catatonic states. Although the association between associated to epilepsy. epilepsy and catatonia has been pointed out in a few review articles (2, 3), little recognition and research have been de- Case Study voted to the association. In every case of catatonic syndrome, Mrs. F’s symptoms were first noticed by her husband a process of clarification of the etiological diagnosis must be when she was 49-years old. He reported that sometimes the performed systematically. patient would suddenly stop talking, turn her head and neck Epilepsy and psychosis coexist more frequently than a little to the right, stare motionless and not interact with chance would predict. Typically, psychotic symptoms closely anyone.
    [Show full text]
  • Catatonia in DSM-5
    Schizophrenia Research 150 (2013) 26–30 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Review Catatonia in DSM-5 Rajiv Tandon a,⁎, Stephan Heckers b, Juan Bustillo c, Deanna M. Barch d,e, Wolfgang Gaebel f, Raquel E. Gur g,h, Dolores Malaspina i,j, Michael J. Owen k, Susan Schultz l, Ming Tsuang m,n,o, Jim van Os p,q, William Carpenter r,s a Department of Psychiatry, University of Florida Medical School, Gainesville, FL, USA b Department of Psychiatry, Vanderbilt University, Nashville, TN, USA c Department of Psychiatry, University of New Mexico, Albuquerque, NM, USA d Department of Psychology, Washington University, St. Louis, MO, USA e Department of Psychiatry and Radiology, Washington University, St. Louis, MO, USA f Department of Psychiatry, Duesseldorf, Germany g Department of Psychiatry, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA h Department of Neurology and Radiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA i Department of Psychiatry, New York University, New York, NY, USA j Creedmoor Psychiatric Center, New York State Office of Mental Health, USA k MRC Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom l Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA, USA m Center for Behavioral Genomics, Department of Psychiatry and Institute of Genomic Medicine, University
    [Show full text]